Insmed’s ‘ginormous’ lung drug sales; J&J’s US pricing deal
Insmed’s ‘ginormous’ lung drug sales; J&J’s US pricing deal
Insmed’s ‘ginormous’ lung drug sales; J&J’s US pricing deal
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.